01—Abstract
Summary
Summary of the 10-K/A filed November 8, 2005. Cited figures are marked; the original filing is the authoritative source.
This filing is an amendment (10-K/A) to Cardinal Health Inc.'s (CAH) 2005 annual report, covering the period ending June 29, 2005, and filed on November 7, 2005.
As an amendment, it primarily serves to provide updated or supplementary information to the original filing. The document lists various exhibits, including financial statement schedules and significant agreements such as wholesale supply agreements with major pharmacy chains (CVS Pharmacy, Inc.) and prime vendor agreements with pharmacy benefit managers (Express Scripts, Inc.). It also details numerous credit agreements, stock incentive plans, and employment agreements for key executives.
For investors, this filing offers transparency into the company's contractual relationships with its key customers and partners, as well as its executive compensation and corporate governance structures. While it does not present new financial results directly, it provides context for the financial performance reported in the main 10-K by detailing the underlying agreements that drive revenue and operational activity. Investors should note the confidentiality requests for certain commercial and financial information within these agreements, which limits full public disclosure but is standard practice.
02—Key points
Key Highlights
- The filing is an amendment (10-K/A) to the 2005 annual report for Cardinal Health Inc. (CAH), filed November 7, 2005.
- It includes a comprehensive list of exhibits, detailing key contractual agreements and corporate documents.
- Significant business agreements highlighted include Wholesale Supply Agreements with CVS Pharmacy, Inc. and Prime Vendor Agreements with Express Scripts, Inc.
- Various indentures related to the company's debt securities are listed, providing insight into its capital structure.
- The filing details multiple credit agreements, including a five-year credit agreement dated March 27, 2003, and an updated one from March 23, 2004.
- Numerous exhibits pertain to stock incentive plans, employee stock purchase plans, and deferred compensation plans, reflecting executive and employee compensation structures.
- Employment agreements for key executives, including Robert D. Walter, George L. Fotiades, Stephen S. Thomas, and J. Michael Losh, are listed.
03—Questions
Frequently Asked Questions
What is the main purpose of this 10-K/A filing?
This filing is an amendment to Cardinal Health Inc.'s 2005 annual report. Amendments are typically filed to correct errors, provide updated information, or supplement the original filing, ensuring that investors have the most accurate and complete data available.
What types of agreements are detailed in the exhibits?
The exhibits detail a wide range of agreements, including significant customer contracts like wholesale supply and prime vendor agreements with major pharmacy chains and pharmacy benefit managers. They also cover debt financing through various indentures and credit agreements, as well as executive compensation and stock incentive plans.
Why is some information in the agreements marked as confidential?
Confidential treatment is requested for certain commercial and financial information within these agreements (like supply agreements with CVS and Express Scripts) to protect competitive business strategies and proprietary details from public disclosure, as permitted by SEC rules. This is a common practice for material contracts.
Does this filing include the company's financial performance for the fiscal year?
This specific filing (10-K/A) is primarily an amendment and focuses on listing exhibits and schedules. While it references the financial statements from the main 10-K (Consolidated Statements of Earnings, Balance Sheets, etc., on pages 47-51), it does not present the core financial results itself. Investors should refer to the original 10-K filing for the detailed financial performance for the fiscal years ended June 30, 2004, 2003, and 2002.
04—Continue